Cardinal Health stock faces a November 5 earnings test

Cardinal Health is heading into its first major test of fiscal 2027 guidance. The healthcare distributor is scheduled to report fiscal first-quarter results before the US market opens on Thursday, November 5, according to MarketBeat.

Expectations set a demanding test

Analysts cited by MarketBeat expect adjusted earnings of USD 2.94 per share and revenue of USD 66.67 billion for the September quarter. The forecast puts the focus on whether Cardinal Health can preserve strong profit growth while revenue expansion moderates from the unusually strong pace seen during the previous fiscal year.

Management's full-year fiscal 2027 adjusted EPS guidance stands at USD 12.40 to USD 12.60. That outlook implies continued earnings growth, but the quarterly release will give investors the first operating evidence of how the company is progressing against that range.

Prior results raise the bar

Cardinal Health reported USD 2.91 in earnings per share for its previous quarter, exceeding the USD 2.42 consensus estimate cited by MarketBeat. Revenue reached USD 63.67 billion and increased 5.8 percent from the prior-year quarter, although it came in below the USD 65.15 billion estimate referenced in the same report.

The mixed quarterly picture leaves the earnings composition important for the stock. A result above expectations could reinforce confidence in the full-year outlook, while a revenue shortfall or weaker operating performance could increase scrutiny of the guidance range. Neither outcome is predetermined by the estimates.

Recent signals for investors

MarketBeat reported that analysts maintained a positive stance, with 16 Buy ratings and three Holds and an average price target of USD 269.38. The report also noted insider sales totaling 210,271 shares worth USD 49.63 million over the preceding 90 days. These factors provide context for sentiment but do not determine the quarterly result.

Cardinal Health stock traded at 224.00 euros on Lang & Schwarz at 11:09 CET on Monday, November 2, 2026. Investors can follow the real-time quote of Cardinal Health stock.

Next catalyst arrives Thursday

The November 5 release is the next scheduled catalyst, with the earnings call set for 8:30 a.m. Eastern Time. Investors will focus on quarterly EPS, revenue, segment performance and any change to the fiscal 2027 outlook.

The S&P 500 provides the broader US market backdrop for Cardinal Health's earnings test.

More news and analysis are available on More news and analyses on Cardinal Health stock.